<?xml version="1.0" ?><ns2:com.thomsonreuters.ls.service.contract.soap.ontology.v1.OntologyDealSummaryOutput xmlns:ns2="local" id="139643"><Title>NRC-IRAP to award iCo Therapeutics funding for the development of oral Amphotericin B against HIV infection</Title><Principal>iCo Therapeutics Inc</Principal><Partner>National Research Council of Canada</Partner><Type>Drug - Funding</Type><Status>Active</Status></ns2:com.thomsonreuters.ls.service.contract.soap.ontology.v1.OntologyDealSummaryOutput>